GoodRx Holdings (GDRX) Free Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 53.98% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 30.81% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 26.21% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 774.21% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 10.61% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 18.30% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -19.89% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -105.58% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 68.61% |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn | 29.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.63% |
| Dec 31, 2025 | -58.95% |
| Sep 30, 2025 | -76.12% |
| Jun 30, 2025 | 650.37% |
| Mar 31, 2025 | -129.21% |
| Dec 31, 2024 | 1,209.28% |
| Sep 30, 2024 | 84.67% |
| Jun 30, 2024 | 681.52% |
| Mar 31, 2024 | 31.24% |
| Dec 31, 2023 | -89.27% |
| Sep 30, 2023 | 41.50% |
| Jun 30, 2023 | -97.94% |
| Mar 31, 2023 | 65.35% |
| Dec 31, 2022 | -23.28% |
| Sep 30, 2022 | -18.81% |
| Jun 30, 2022 | 107.10% |
| Mar 31, 2022 | -49.52% |
| Dec 31, 2021 | 314.49% |
| Sep 30, 2021 | 73.24% |
| Jun 30, 2021 | -12.64% |
| Mar 31, 2021 | -14.28% |
| Dec 31, 2020 | -44.80% |